# US 2012/0251623 A1 · Method of administering an active ingredient using a chewable oral dosage from comprising texture masked particles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251623 A1
- Document ID: US20120251623A1
- Status: Published application
- Kind: A1
- Application number: 13/494,361
- Filed: 2012-06-12
- Published: 2012-10-04
- Earliest claimed: 2000-12-21
- Inventors: Narendra Parikh; Daniel McTeigue; David W. Wynn; Ravivaj S. Pillai
- Web page: https://patentgrep.com/patent/US20120251623A1

## CPC

- A61K 9/5073: {having two or more different coatings optionally including drug-containing subcoatings}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K 9/2081: {with microcapsules or coated microparticles according to A61K9/50}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

In one aspect, the present invention features a method of administering an active ingredient, said method comprising chewing an oral dosage form comprising a texture masked particle, said texture masked particle comprising a) a core containing an active ingredient; b) a first coating layer comprised of a taste masking agent that substantially covers the core, wherein said taste masking agent is comprised of an insoluble film forming polymer and a non-enteric, water soluble polymer; and c) a second coating layer on the surface of the first coating layer.

## Claims

### Claim at position 1

1-72. (canceled)

### Claim 73

A method of administering an active ingredient, said method comprising chewing an oral dosage form comprising a texture masked particle, said texture masked particle comprising
a) a core containing an active ingredient;
b) a first coating layer comprised of a taste masking agent that substantially covers the core, wherein said taste masking agent is comprised of an insoluble film forming polymer and a non-enteric, water soluble polymer; and
c) a second coating layer on the surface of the first coating layer, the second coating layer comprising:
i) a water soluble and/or water swellable film forming polymer; and
ii) an anti-grit agent selected from the group consisting of polyethylene oxide, polyethylene glycol, and mixtures thereof,
wherein said second coating layer does not retard the dissolution of said active ingredient and the weight ratio of water soluble and/or water swellable film forming polymer to anti-grit agent in the second coating layer is in the range of about 20:80 to about 80:20.

### Claim 74 (depends on 73)

The method of claim 73, wherein the insoluble film forming polymer is selected from the group consisting of cellulose acetate, ethylcellulose, and mixtures thereof.

### Claim 75 (depends on 73)

The method of claim 73, wherein the water soluble and/or water swellable film forming polymer is selected from the group consisting of hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, and sodium carboxy methyl cellulose, starches, alginates, polyvinyl alcohols, xanthan gums, guar gums, polysaccharides, pectins, gelatins, and mixtures thereof.

### Claim 76 (depends on 73)

The method of claim 73, wherein the non-enteric, water soluble polymer is selected from the group consisting of hydroxypropyl cellulose, poly(ethylacrylate, methyl methacrylate), and mixtures thereof.

### Claim 77 (depends on 74)

The method of claim 74, wherein the non-enteric, water soluble polymer is selected from the group consisting of hydroxypropyl cellulose, poly(ethylacrylate, methyl methacrylate), and mixtures thereof.

### Claim 78 (depends on 73)

The method of claim 73, wherein the second coating layer is comprised of a mixture of hydroxypropyl methylcellulose and polyethylene glycol.

### Claim 79 (depends on 74)

The method of claim 74, wherein the second coating layer is comprised of a mixture of hydroxypropyl methylcellulose and polyethylene glycol.

### Claim 80 (depends on 76)

The method of claim 76, wherein the second coating layer is comprised of a mixture of hydroxypropyl methylcellulose and polyethylene glycol.

### Claim 81 (depends on 77)

The method of claim 77, wherein the second coating layer is comprised of a mixture of hydroxypropyl methylcellulose and polyethylene glycol.

### Claim 82 (depends on 73)

The method of claim 73, wherein the weight ratio of film forming polymer to anti-grit agent in the second coating layer is in the range of about 60:40 to about 40:60.

### Claim 83 (depends on 82)

The method of claim 82, wherein the weight ratio of film forming polymer to anti-grit agent in the second coating layer is in the range of about 60:40 to about 40:60.

### Claim 84 (depends on 73)

The method of claim 73, wherein the taste masking agent is further comprised of an enteric polymer.

### Claim 85 (depends on 84)

The method of claim 84, wherein the enteric polymer is selected from the group consisting of hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, and mixtures thereof.

### Claim 86 (depends on 82)

The method of claim 82, wherein the taste masking agent is further comprised of an enteric polymer.

### Claim 87 (depends on 86)

The method of claim 86, wherein the enteric polymer is selected from the group consisting of hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, and mixtures thereof.

### Claim 88 (depends on 73)

The method of claim 73, wherein the active ingredient is selected from the group consisting of a nonsteroidal anti-inflammatory drug, acetaminophen, pseudoephedrine, phenylpropanolamine, chlorpheniramine, dextromethorphan, diphenhydramine, dimenhydrinate, meclizine, famotidine, loperamide, ranitidine, cimetidine, astemizole, loratadine, desloratadine, fexofenadine, cetirizine, antacids, pharmaceutically acceptable salts thereof, metabolites thereof, and mixtures thereof.

### Claim 89 (depends on 82)

The method of claim 82, wherein the active ingredient is selected from the group consisting of a nonsteroidal anti-inflammatory drug, acetaminophen, pseudoephedrine, phenylpropanolamine, chlorpheniramine, dextromethorphan, diphenhydramine, dimenhydrinate, meclizine, famotidine, loperamide, ranitidine, cimetidine, astemizole, loratadine, desloratadine, fexofenadine, cetirizine, antacids, pharmaceutically acceptable salts thereof, metabolites thereof, and mixtures thereof.

### Claim 90 (depends on 73)

A method of claim 73, wherein said particle has an average diameter of about 50 microns to about 500 microns.

### Claim 91 (depends on 82)

A method of claim 82, wherein said particle has an average diameter of about 50 microns to about 500 microns.

### Claim 92 (depends on 73)

The method of claim 73, wherein the oral dosage form is a chewable tablet or a rapidly disintegrating tablet, and the excipient is comprised of a water soluble compressible carbohydrate.

### Claim 93 (depends on 82)

The method of claim 82, wherein the oral dosage form is a chewable tablet or a rapidly disintegrating tablet, and the excipient is comprised of a water soluble compressible carbohydrate.
